Seegene, Samsung Enter Cancer MDx Pact

The deal also takes Seegene into the personalized medicine space. In addition to tests for detecting cancer, the two companies will develop tests to determine how patients respond to cancer therapies.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.